Drug Database
Back to search

Poland· PL-100539095

DicloDuo Combi

A medicinal product containing diclofenacum natricum + omeprazolum, registered in Poland by InPharm Sp. z o.o..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDicloDuo CombiATC—REGISTER NO.PL-100539095PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about diclofenacum natricum + omeprazolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

URPL (Poland)
Active substance
Diclofenacum natricum + Omeprazolum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909991602109
  • gtin
    05909991602116
  • gtin
    05909991602123
  • gtin
    05909991602130
  • gtin
    05909991602147
  • gtin
    05909991602154

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diclofenacum natricum + omeprazolum in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenacum natricum + omeprazolum products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Arthrocomb
  • Bulgaria · Диклопрам
  • Cyprus · Dicloduo Combi
  • Germany · Diclofenac/Omeprazol, Diclofenac/Omeprazol Aristo Aristo
  • Estonia · Diclopram
  • Greece · Dicloduo Combi
  • Hungary · Diclopram
  • Lithuania · Diompraz
  • Latvia · Diompraz
  • Malta · Dicloduo Combi
  • Slovakia · Diompraz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee3419e4-fd64-4e9a-b537-6d92d4b766ad
GET /v1/drugs/ee3419e4-fd64-4e9a-b537-6d92d4b766ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki o zmodyfikowanym uwalnianiu, twarde",
  "source": "urpl",
  "strength": "75 mg + 20 mg",
  "packaging": "05909991602109 ¦ Rp ¦ 167189\n10 kaps.\n05909991602116 ¦ Rp ¦ 167190\n20 kaps.\n05909991602123 ¦ Rp ¦ 167191\n30 kaps.\n05909991602130 ¦ Rp ¦ 167192\n50 kaps.\n05909991602147 ¦ Rp ¦ 167193\n60 kaps.\n05909991602154 ¦ Rp ¦ 167194\n100 kaps.",
  "substance": "Diclofenacum natricum/75 mg + Omeprazolum/20 mg",
  "common_name": "Diclofenacum natricum + Omeprazolum",
  "pl_product_id": "100539095",
  "pozwolenie_nr": "204/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-05-21"
}
API referenceMCP serverPlans

See everything about diclofenacum natricum + omeprazolum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console